AIM
RGNX icon

Assured Investment Management’s Regenxbio RGNX Stock Holding History

Assured Investment Management’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-1,107
Closed -$46K – 1326
2018
Q4 		$46K Buy
1,107
+195
+21% +$11.4K ﹤0.01% 1043
2018
Q3 		$69K Sell
912
-3,199
-78% -$230K ﹤0.01% 1074
2018
Q2 		$295K Sell
4,111
-29,018
-88% -$1.39M 0.01% 938
2018
Q1 		$989K Buy
+33,129
New +$964K 0.02% 552

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
WM
WS Management Jacksonville, Florida $1.14B AUM 139.27% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Assured Investment Management's RGNX Position: Q1 2019 in Review

Assured Investment Management sold out of Regenxbio (RGNX) in Q1 2019, closing a stake of 1,107 shares — an estimated $46K sold.

Assured Investment Management first reported a position in RGNX in Q1 2018 and held it in 4 quarters. The position peaked at $989K in Q1 2018. 211 funds tracked by Wall St. Rank hold RGNX as of Q1 2019.

  • Assured Investment Management reported no remaining Regenxbio position as of Q1 2019 after selling out during the quarter.
  • Assured Investment Management sold 1,107 Regenxbio shares in Q1 2019, an estimated $46K.
  • Assured Investment Management first reported a position in Regenxbio in Q1 2018 and held it in 4 quarters.
  • Assured Investment Management's Regenxbio position peaked at $989K in Q1 2018.
  • 211 funds tracked by Wall St. Rank held Regenxbio as of Q1 2019.

Based on Assured Investment Management's 13F filing for Q1 2019, filed 16 May 2019.